版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
COMBATINGCOUNTERFEITDRUGSININDONESIAFirstASEAN-ChinaConferenceonCombatingCounterfeitMedicalProductsJakarta,13-15November2007NationalAgencyofDrugandFoodControlIndonesiaBACKGROUNDlocatedbetweentwocontinentsandtwooceans,whichiseasilyaccessiblebyland,sea,orair.someproblemsarestillbeingfaced,blemsmayarisefromborderlineareas,whicharesusceptibletosmuggled,counterfeitmedicines.RegardingcounterfeitmedicinestheymaybeIllegallyimportedorLocallymanufacturedbyillegalmanufacturerINDONESIADistributedtoillegalmarketFREETRADEZONEFreeTradeZoneBATAM,includingBatamIsland,TontonIsland,SetotokIsland,NipahIsland,RempangIsland,GalangIslandandGalangBaruIsland.FreeTradeZoneBINTAN,includingGalangBatangIndustrialEstate,MaritimIndustrialEstate,andLobanIsland,SenggarangIndustrialEstateandDompakBaratIndustrialEstateFreeTradeZoneKARIMUN,includingnumberofKarimunIsland,KarimunAnakIslandFreeTradeZoneSABANG.NUMBEROFINTERNATIONALPORTSEAPORT:141AIRPORT:10
LEGISLATIVE
INFRASTRUCTUREBORDERPOSTEffortshavebeentakenbyestablishingBorderPostsinsomeareas,i.e:SKOU(PapuaNewGuinea)MOTAAIN,NAPAN&METAMAUK(TimorLeste)MARORE&MIANGAS(Philipine)ENTIKONG&JAGOIBABANG(EastMalaysiaLand)NUNUKAN(EastMalaysiaOcean)SUNGAIGUNTUNG(WestMalaysiaOcean)SAMBUBELAKANG,PADANG&TAREMPA(WestMalaysiaOcean)Objective:
TocontrolimportedgoodsTominimizeillegal&counterfeitdrugsenteringthecountryDefinitionCounterfeitDrugs(CD’s)definitioninIndonesiabasedonIndonesianMoHDecreeNo.949/2000:Amedicinalproductwhichismanufacturedbyillegalmanufacturerordeliberatelymislabeledwithrespecttoidentityofregisteredproduct.BasicLawandRegulationrelateddrugcounterfeitingLawNo.1/1946onCriminalActLawNo.23/1992onHealthLawNo.8/1999onConsumerProtectionLawNo.14/2001onPatentLawNo.15/2001onMarkNUMBEROFCASESCOUNTERFEITDRUGSFINDINGFREQUENCIES
PERIOD2001-2007(October)frequency*Thedataismadefromfindingfrequencies>3timesCounterfeitdrugsNUMBEROFCASESSUSPECTEDCONFIRMEDIMPORTED/DOSMETICVITALMEDICAL20072*2ImportandDomesticYes200611DomesticNo200533DomesticYes(injectable)*aresultofjointoperationwherebyanillegalwarehousewasfoundfilledwiththousandofboxesof26itemsofcounterfeitmedicines,withanestimatedvalueofupto25billionrupiahsHOWWHERETHESECASESDETECTED%ornumberofcasesPatientscomplaintsNODATAAVAILABLEHealthprofessionalsreportsNODATAAVAILABLEEnforcement/investigationworkNODATAAVAILABLERoutinechecksNODATAAVAILABLEReportedbyaffectedmanufacturer28,6%(2005),20%(2006),4,16%(2007)NUMBEROFPROSECUTIONS/CONVICTIONS/PENDINGMANUFACTURERWHOLESALER/IMPORTERRETAILERINFORMALSECTOR20071(inprocess)1(inprocess)2006--1(inprocess)-2005--3(2Sentencepenalty,1WantedList)-NADFCDATANATIONALCOORDINATIONMechanismofnationalcoordination
CombatingCounterfeitDrugsrequiresjointeffortDrug/NationalRegulatoryAuthorityHealthcare&medicineprovidersCivilsocietiesPatientInterestGroupsPatients/consumersDrugmanufacturersimporters&wholesalersmedicinesMinistries,police,customs,ProsecutorsGovernmentmedicinesBENEFITS&LIMITATIONSOFCOORDINATIONBENEFITSTechnicalsupportsuchaslaboratorytest,expertwitnessstatementwillbeprovidedbyNADFCifneededIffacingdifficulties,forceeffortwillbeprovidedbythePoliceProvidedinformationofimport-registeredproductsforthecustomSeveralLawsandregulationasbasiclegalprocesstocombatCounterfeitDrugsareavailableLIMITATIONSLackofthereferencestandardavailableinNQCLLackofcoordinationamonglawenforcementagenciesatalllevel(National-provincial-district)On-linesystemisnotinplaceWeaknessofImplementationofsomeLaws,suchasneedappealfromthemanufacturingauthorizationholderofauthenticdrugsSTRATEGICACTIONONCOMBATINGCOUNTERFEITDRUGS(CDs)inINDONESIAILEGALMANUFACTURERILLEGALMARKETILEGALDISTRIBUTORCONSUMERFACTS:CDsarefound,mostlyinillegalmarketDifficulttodifferenciatewiththegenuineoneLackofpublicawareness(consumersbuydrugsintheillegalmarket)STRATEGIES:BreakinguptheIllegalchainSustainablelawenforcementwithdeterrentpenaltiesRevealmodusoperandi,identifytheintellectualactorsandtheirnetwork
NationalProgram;Comprehensiveinvestigationandmopping-upwhatisalreadyincirculationNationalJointOperationandjointinvestigatinwithpolice(inilegalmarket)StrenghteningtheinfrastructureImprovementcollaborationandcoordinationwithotherlawenforcementagenciesIncreasingcomprehensivedrugdistributioncontrolIncreasingpublicawarenessandlawenforcementagenciesREGIONALLEVELGAPSIMPLICATIONSSTRATEGYInter-sectoralcoordinationisnotbasedonwrittenprocedurewhichareclearlydefinedroles,adequateresourcesandeffectiveadministrativeandoperationaltools.Lackofawarenessabouttheseverityoftheproblemamongstakeholder.NospecificlawonCounterfeitDrugs.LimitationofreferencestandardonNQCLNocomprehensiveprogramoncombatingcounterfeitdrugsNodeterrentsanctionsNodeterrentsanctionsThetimelineoflabresultisnotonscheduleDevelopnationaltskforceoninter-sectoralcoordinationbaseonwrittenprocedures,clearlydefinedroles,adequateresources,andeffectiveadministrativeandoperationaltools.Increasingawarenessontheharmful/impactofcounterfeitdrugsthroughseminarforthespecifictargetgroupssuchasPharmaceuticalManufacturer,Healthprofessionals,patients,trainingforLawenforcementAgencies,andDRAAssistnationalauthoritiestodevelopriskcommunicationandadvocacymaterialsDevelopdraftoncounterfeitdrugsLawNeedcollaborationtogetreferenceatandardassistbyWHOREGIONALLEVELGAPSIMPLICATIONSSTRATEGYLackofInformationExchangeamongcountries,nodesignatedpersoninchargeatDRADifferentdefinitionofCounterfeitDrugsamongCountriesLackofnetworkingonCounterfeitdrugsproblemamongASEANDRAs
difficultiesoncontactingthepersoninchargeDifferentfollowupactiondifficultytoknowthegenuityofthesuspecteddrugDifficultytotracethesuspectiftheyescapetoothercountriesPromotenetworkingandcollaborationamongASEANDRAoncounterfeitdrugsDevelopTORwhichareincludediscussionamongASEANcountrieson:thedefinitionofcounterfeitdrugs.Surveyexistingnationalandinternationallegislation&requirementsAssessexistingnationalbestpracticesanddevelopmodelbestpracticesPromotesecureexchangeofinformationandalertsamongASEANDRADevelopmentofcommondefinitionofcounterfeitdrugwithinASEANCountriesDevelopmentASEANSchemeontacklingofcounterfeitdrugsDevelopmentaRegionalStrategyandSystematicProgramProposedProjectagainstCounterfeitDrugsOUTPUTExchangeofinformationbydesignatedunitofDRADevelopdatabaseofcounterfeit
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024-2030年撰寫:中國α戊基桂醇項目風險評估報告
- 2024-2030年抗堿封閉底面處理劑搬遷改造項目可行性研究報告
- 2024-2030年山東省煤炭產(chǎn)業(yè)發(fā)展狀況投資規(guī)模分析報告權(quán)威版
- 2024-2030年國家甲級資質(zhì):中國京式炸雞爐融資商業(yè)計劃書
- 2024-2030年史地桌公司技術(shù)改造及擴產(chǎn)項目可行性研究報告
- 2024-2030年雙級制冷壓縮機公司技術(shù)改造及擴產(chǎn)項目可行性研究報告
- 2024-2030年冷凍梁系統(tǒng)行業(yè)市場現(xiàn)狀供需分析及重點企業(yè)投資評估規(guī)劃分析研究報告
- 2024-2030年全球及中國輝光放電質(zhì)譜儀(GDMS)市場銷售態(tài)勢與營銷渠道分析報告
- 2024-2030年全球及中國自燃點測試儀行業(yè)發(fā)展狀況及投資前景預(yù)測報告
- 2024-2030年全球及中國空氣炸鍋烤面包機行業(yè)營銷態(tài)勢及銷售渠道策略報告
- 大學無機及分析化學----氣體練習題及答案
- 北師大版數(shù)學初二上冊知識點總結(jié)
- 鐵路建設(shè)項目施工企業(yè)信用評價辦法(鐵總建設(shè)〔2018〕124號)
- 模具報價表精簡模板
- 形式發(fā)票模板 PI模板 英文版
- 初一的最美的風景高分的作文600字
- 高考英語單項選擇題題庫題
- 檢驗檢測機構(gòu)資質(zhì)認定現(xiàn)場評審日程表及簽到表
- 完整版高低壓開關(guān)柜投標文件技術(shù)標
- 蘭州市行政區(qū)劃代碼表
- 管鮑之交-歷史劇劇本(共4頁)
評論
0/150
提交評論